Chronic obstructive pulmonary disease (COPD)
COPD is a serious progressive long‐term lung disease estimated to affect 9–10% of adults over 40 years of age.1 The latest figures from the World Health Organization2 show that 65 million people across the globe are living with moderate to severe COPD.
Over the next decade, the number of deaths associated with COPD is predicted to increase by more than 30% to become the third leading cause of death worldwide by 20302.
For over 25 years ResMed has been working to improve the lives of people with COPD and other breathing disorders. We're continually innovating to produce more advanced solutions for people with these conditions.
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to describe chronic lung diseases in which breathing is severely restricted because of lung damage and inflammation, usually as a result of tobacco smoke. In non-smokers, COPD may be caused by occupational exposure to smoke, dust or chemicals.
COPD-OSA overlap syndrome
Overlap syndrome is a term used to describe the coexistence of obstructive sleep apnea (OSA) and COPD, and was first coined by researcher David Flenley when he estimated that this association of two common diseases probably involved many patients.
Treating COPD with NIV
Hypercapnic patients (characterized by increased levels of CO2 in the blood) are primary candidates for non-invasive ventilation (NIV) as it seeks to improve the patient’s CO2 exchange and support the work of breathing when the patient's own physiology cannot do so effectively.
ResMed’s NIV technologies
We offer end-to-end NIV solutions – combining a comprehensive range of ventilators with AirView™ remote monitoring and the #1 mask brand preferred by patients .
How can we help you manage your COPD patient population?
We will work with you to identify which patients are appropriate for NIV therapy, and provide tools to help you monitor your COPD population – particularly in the critical 30 days post-hospital discharge. Complete the form below to contact us and learn how we can help you provide better care for your COPD patient population.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. http://www.goldcopd.org/
World Health Organization. World Health Statistics 2008. Global Health Observatory (GHO). http://www.who.int/gho/publications/world_health_statistics/en/